PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$81.17 USD
+0.39 (0.48%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $81.22 +0.05 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum D VGM
PROCEPT BioRobotics Corporation (PRCT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$102.75 | $112.00 | $95.00 | 27.20% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for PROCEPT BioRobotics Corporation comes to $102.75. The forecasts range from a low of $95.00 to a high of $112.00. The average price target represents an increase of 27.2% from the last closing price of $80.78.
Analyst Price Targets (8 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
PROCEPT BioRobotics Corporation currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.44 a month ago based on nine recommendations.
Of the 10 recommendations deriving the current ABR, eight are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 77.78%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 7 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.44 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
12/3/2024 | Wells Fargo Securities | Nathan Treybeck | Strong Buy | Strong Buy |
11/25/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
9/16/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
9/2/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
8/2/2024 | William Blair | Brandon Vazquez | Strong Buy | Strong Buy |
8/2/2024 | Truist Securities | Richard Newitter | Strong Buy | Strong Buy |
8/1/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 10 |
Average Target Price | $102.75 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 54 of 251 |
Current Quarter EPS Est: | -0.35 |
PRCT FAQs
PROCEPT BioRobotics Corporation (PRCT) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for PROCEPT BioRobotics Corporation (PRCT) is $102.75. The current on short-term price targets is based on 8 reports.
The forecasts for PROCEPT BioRobotics Corporation (PRCT) range from a low of $95 to a high of $112. The average price target represents a increase of $26.59 from the last closing price of $81.17.
The current UPSIDE for PROCEPT BioRobotics Corporation (PRCT) is 26.59%
Based on short-term price targets offered by eight analysts, the average price target for PROCEPT BioRobotics Corporation comes to $102.75. The forecasts range from a low of $95.00 to a high of $112.00. The average price target represents an increase of 27.2% from the last closing price of $80.78.